Tcellogy
Seoul
About Tcellogy
Tcellogy creates personalized cancer vaccines that stimulate T-cell responses against neoepitopes. Tcellology improves cancer patients' quality of life by contributing to the development of patient-specific cancer vaccines that embody the concept of precision medicine by establishing an Omics-level T cell-related information DB and providing more precise neoantigen epitope prediction technology.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Last round: Series Unknown (Jan 2023)
- Website: tcellogy.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Therapeutics
Canonical: https://fsome.com/organization/tcellogy-326794 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.